Supplement manufacturer Biohm Health has announced a $7.5 million cash infusion that the company says will help it to further develop the use of artificial intelligence in its product formulations.
The dietary supplement industry has often been billed as recession proof. But is it inflation proof? Attendees at a recent industry gathering weren’t so sure.
Omaha-based supplement marketer FitLife Brands has reported promising full year revenue that comes with a serious caveat in that the company may need to restate its financial results going back to its 2019 fiscal year.
Microbial sciences company Seed Health is eyeing new categories, accelerated global distribution, and an expanded clinical research program after closing a Series A financing round.
The French government's financing initiative has approved Seventure’s Health for Life Capital fund meaning investors will devote over €5 billion to innovative companies in the field of the microbiome before the end of 2022.
Beauty from within, a perpetually not quite ready for prime time category in North American, seems to finally have arrived with the success of HUM Nutrition, which announced an additional $5 million infusion of cash this week.
Ingredient supplier Bayir Group has announced $2.45 million in funding which will be used for a manufacturing expansion primarily aimed at pharmaceutical applications.
Cardax, a Hawaii-based developer of synthetic astaxanthin, announced that the company’s proprietary carotenoid compound has been chosen for a National Institute on Aging test program.
Having a crisis communications plan in place to deal with allegations of financial impropriety is a must for a public company, as ChromaDex Corp recently learned to its chagrin.
Investment experts and industry-leading entrepreneurs will provide insights and tips on how to improve the odds of successfully obtaining financing during the upcoming “Financing Your Consumer Products Company” seminar.
Dietary supplement heavyweight GNC Holdings has started a review of a wide range of strategic and financial alternatives to increase shareholder value.
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
ChromaDex Corp. has announced an additional $5 million in funding from Hercules Technology Growth Capital. The cash infusion will fund operations for a number of months as the company moves toward profitability, said CEO Frank Jaksch.
Danone shares rose today as rumours strengthened the French dairy giant would sell its medical and paediatric nutrition business (Nutricia), but is the firm streamlining its activities around its core foods businesses or just shifting infant-medical...
Michael Nuzzo, executive VP and CFO of GNC Holdings, Inc., has tendered his resignation in order to accept an executive position at a private equity funded consumer products company.
SmartyPants Vitamins has just announced that it has closed a $2.2 million second round of financing via CircleUp, bringing their crowdfunding total to $4.7 million, but what separates this company from other supplement entrepreneurs?
SmartyPants Vitamins, which specializes in delivering vitamin formulas via a gummy delivery system, has raised $2.59 million via a crowd funding platform to drive new growth. Getting the money was nice, but saving time was even better, said company co...
Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012. Within that number, the group noted a decline in the number of M&A deals from the previous year, but an increase in financings.
Neptune Technologies and Bioressources has announced a plan to recover from an explosion and fire at its processing plant in Sherbrooke, Quebec that put a halt to production of the company’s krill oil products.
Management at embattled resveratrol supplier Fluxome has come in for severe criticism as the company hovers on the verge of financial collapse unless a fresh investor can be found in the coming weeks.
NuMe Health - the New Orleans-based firm behind NM504, a novel ‘cobiotic’ ingredient targeting prediabetics - has secured a $1.5m cash injection to support plans to commercialize it.
Canadian krill oil firm Neptune Technologies & Bioressources has begun the first phase of an expansion project at its facility in Sherbrooke, Québec that will see production double to 300,000kg of Neptune Krill Oil (NKO) per year.
Neptune Technologies & Bioressources has secured a chunk of funds through a new financing agreement, which the firm says will help to double its production capacity of krill oil.
KGK Synergize has a full pipeline of new nutraceutical products,
and is seeking additional growth capital of between C$7 and $10m to
bring them to market over the coming years.
Bravo! Foods is planning to increase production capacity of its
fortified flavored milk products - a plan that will be facilitated
by almost $19 million in equity financing.
UK dosage form specialist BioProgress gave the first insight into
its much-anticipated strategic review yesterday, just over a month
after the departure of former CEO Graham Hind, reports Phil
Taylor.
Up-and-coming Advanced Bionutrition (ABN) has captured the
attention of venture capitalists in the biotechnology field,
raising $7.5 million in a second round of private equity funding.
Leiner Health Products, a leading manufacturer of store brand
vitamins, minerals, and nutritional supplements, has seen a solid
financial performance in the first quarter of fiscal 2005 as its
new capital structure came into play.
Moody's Investor Services yesterday downgraded Cargill's debt
ratings, citing factors including the uncertainty surrounding
Cargill's strategy with regard to future acquisitions and increased
capital expenditure.
Canadian biotech firm Forbes Medi-Tech announced today it has
raised US$4.65 million by way of a private placement, providing the
company with the necessary resources to 'expand its pharmaceutical
pipeline and continue development...
Swiss speciality chemicals group Lonza announced yesterday that it
was to restructure two business sectors, resulting in the loss of
225 jobs or 3 per cent of its 6,400 workforce.
Vanson HaloSource, the US company which specialises in
chitosan-based products, has completed a new round of financing
which will help it finance the development of new supplement
products.
Vital Living sucessfully completes private placement, raising more
than $3m, but Herbalife finds there is little interest in its bond
issue from European investors.